Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a nordic diet help kids with Crohn's?

NCT ID NCT07334340

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a Nordic version of the Crohn's Disease Exclusion Diet in 30 children aged 6-18 with mild-to-severe Crohn's disease. The diet avoids inflammatory foods and gradually reintroduces unprocessed items over 20 weeks. Researchers will measure remission rates, diet adherence, and quality of life, comparing results to published data on the original diet.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nordic Crohn's Disease Exclusion Diet (N-CDED)
What this could lead to
If successful, this diet could offer a more personalized and easier-to-follow nutritional therapy for children with Crohn's disease, potentially reducing symptoms and the need for steroids.
What could go wrong
This is a small, early-stage study with only 30 participants and no control group, so results may not apply to all children. The diet is demanding and may be hard to stick with long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Jan 2030

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 6-18 years with recent (\<36 months) mild-to-severe CD diagnosis (defined as Paediatric Crohn's Disease Activity Index \[PCDAI\] 15-47.5) * Evidence of active inflammation (C-reactive protein \[CRP\] ≥ 0.5 mg/dL, erythrocyte sedimentation rate \[ESR\] ≥ 20 mm/h, and/or faecal calprotectin \[FCP\] ≥ 200 mg/g during screening) * Stable use of medication other than steroids. Exclusion Criteria: * Eating disorders, * Active extraintestinal manifestations * Use of systemic corticosteroids * Active perianal disease * Positive stool cultures for pathogens, parasites, or Clostridioides difficile * Fever \>38.3°C * Documented cow's milk protein allergy * Diabetes, celiac disease and/or psychosocial difficulties.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pediatric crohns disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Queen Silvia's Children's and Adolescent Hospital

    Gothenburg, 41685, Sweden

  • Skaraborg Hospital Skövde, Pediatric Clinic

    Skövde, 54949, Sweden

  • Skånes University Hospital

    Malmö, Skåne County, 214 28, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.